HIV-1 inhibitor-29 structure
|
Common Name | HIV-1 inhibitor-29 | ||
|---|---|---|---|---|
| CAS Number | 2642217-95-4 | Molecular Weight | 560.64 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H36N6O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HIV-1 inhibitor-29HIV-1 inhibitor-29 (compound 14d2) is a potent HIV-1 inhibitor with an EC50 of 2.18 μM for HIV-1 IIIB. HIV-1 inhibitor-29 has high anti-resistance profile toward F227L/V106A strain (EC50 = 0.974 μM), and exhibits low cytotoxicity in MT-4 cells (CC50 = 211 μM). HIV-1 inhibitor-29 can be used for researching AIDS[1]. |
| Name | HIV-1 inhibitor-29 |
|---|
| Description | HIV-1 inhibitor-29 (compound 14d2) is a potent HIV-1 inhibitor with an EC50 of 2.18 μM for HIV-1 IIIB. HIV-1 inhibitor-29 has high anti-resistance profile toward F227L/V106A strain (EC50 = 0.974 μM), and exhibits low cytotoxicity in MT-4 cells (CC50 = 211 μM). HIV-1 inhibitor-29 can be used for researching AIDS[1]. |
|---|---|
| Related Catalog | |
| Target |
HIV (IIIB):2.18 μM (EC50) HIV-1 (F227L/V106A):0.974 μM (EC50) |
| References |
| Molecular Formula | C30H36N6O5 |
|---|---|
| Molecular Weight | 560.64 |